PROGRAM
| |
13.00-13.05 | Welcome & Introduction
Markus Böhm (Münster), Ralf Paus (Miami, USA & Manchester, UK) |
13.05-13-35 | Lecture 1 The role of hormones in hidradenitis suppurativa pathogenesis: A speculative re-exploration (20 min + 10 min discussion) Kelsey van Straalen (Michigan, USA)
|
13.35-13.50 | Oral presentation from selected ESDR poster abstracts Skin-derived beta-endorphin mediates radiation therapy fatigue (#531) (10 min + 5 min discussion) Laos V. Kemeny (Budapest, Hungary)
|
13.50-14.05 | Oral presentation from selected ESDR poster abstracts Type 2 cytokines regulate dermal adipocyte function early in life through hormone-sensitive lipase (#322) (10 min + 5 min discussion) Sabrina Satzinger (Cologne, Germany)
|
14.05-14.20 | Oral presentation from selected ESDR poster abstracts Role of calcitonin gene-related peptide in atopic dermatitis (#413) (10 min + 5 min discussion) Saly Abdelhadi (Stockholm, Sweden)
|
14.20-14.50 | Lecture 2 Human scalp hair follicles operate a fully functional peripheral equivalent system of the central hypothalamic-pituitary-somatotropic (HPS) axis (20 min + 10 min discussion) Ralf Paus (Miami, USA & Manchester, UK)
|
14.50-15.20 | COFFEE BREAK |
15.20-15.50 | Lecture 3 Neuroendocrine mediators and cutaneous senescence (20 min + 10 min discussion) Markus Böhm (Münster, Germany)
|
15.50-16.05 | Oral presentation from selected ESDR poster abstracts GRP induces prometastatic signaling in melanoma (#425) (10 min + 5 min discussion) Jérémy Raymond (Orsay, France)
|
16.05-16.20 | Oral presentation from selected ESDR poster abstracts Human hair follicles can “taste”: Stimulation of the bitter taste receptor TAS2R4 inhibits hair growth ex vivo by up-regulating TGF-β2 (#571) (10 min + 5 min discussion) Jennifer Gherardini (Miami, USA)
|
16.20-16.35 | Oral presentation from selected ESDR poster abstracts Melatonin induces melanoma cell death and synergizes with BRAF/MEK inhibitors by altering cell bioenergetics (#484) (10 min + 5 min discussion) Konrad Kleszczynski (Münster, Germany)
|
16.35-17.05 | Lecture 4 Cannabinoids in dermatology – current state and future directions (20 min + 10 min discussion) Tamas Biro (Debrecen, Hungary) |
17.05-17.35 | Podium Discussion “If I had to choose only one innovative & important frontier in dermatoendocrinology research on which I’d love to fully focus over the next 2 years, assuming I had the funding & manpower, which one would this be?” |
17.35-17.40 | Closing Remarks Markus Böhm (Münster), Ralf Paus (Miami, USA & Manchester, UK) |